[go: up one dir, main page]

NO20015488L - 14 <beta> -H-sterols, pharmaceutical compositions comprising them, and the use of these derivatives for the preparation of bio-regulating drugs - Google Patents

14 <beta> -H-sterols, pharmaceutical compositions comprising them, and the use of these derivatives for the preparation of bio-regulating drugs

Info

Publication number
NO20015488L
NO20015488L NO20015488A NO20015488A NO20015488L NO 20015488 L NO20015488 L NO 20015488L NO 20015488 A NO20015488 A NO 20015488A NO 20015488 A NO20015488 A NO 20015488A NO 20015488 L NO20015488 L NO 20015488L
Authority
NO
Norway
Prior art keywords
sterols
preparation
pharmaceutical compositions
bio
beta
Prior art date
Application number
NO20015488A
Other languages
Norwegian (no)
Other versions
NO20015488D0 (en
Inventor
Peter Esperling
Joachim Kuhnke
Henry Laurent
Thorsten Blume
Christa Hegele-Hartung
Monika Lessl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20015488D0 publication Critical patent/NO20015488D0/en
Publication of NO20015488L publication Critical patent/NO20015488L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse angår farmasøytisk aktive 14p-H-ster- oler, farmasøytiske blandinger omfatt- ende disse og anvendelse av disse nye forbindelser for fremstilling av medi- kamenter. Det har mer spesielt vist seg at 14p-H-sterolene ifølge oppfinnelsen kan anvendes for å regulere meiose.The present invention relates to pharmaceutically active 14β-H sterols, pharmaceutical compositions thereof and the use of these novel compounds for the preparation of medicaments. More specifically, it has been found that the 14β-H sterols of the invention can be used to control meiosis.

NO20015488A 1999-05-10 2001-11-09 14 <beta> -H-sterols, pharmaceutical compositions comprising them, and the use of these derivatives for the preparation of bio-regulating drugs NO20015488L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99250153 1999-05-10
PCT/EP2000/004092 WO2000068245A1 (en) 1999-05-10 2000-05-05 14β-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS

Publications (2)

Publication Number Publication Date
NO20015488D0 NO20015488D0 (en) 2001-11-09
NO20015488L true NO20015488L (en) 2002-01-09

Family

ID=8241145

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015488A NO20015488L (en) 1999-05-10 2001-11-09 14 <beta> -H-sterols, pharmaceutical compositions comprising them, and the use of these derivatives for the preparation of bio-regulating drugs

Country Status (18)

Country Link
EP (1) EP1177205A1 (en)
JP (1) JP2002544136A (en)
KR (1) KR20020013541A (en)
CN (1) CN1350543A (en)
AU (1) AU4756100A (en)
BG (1) BG106093A (en)
BR (1) BR0010449A (en)
CA (1) CA2373442A1 (en)
CZ (1) CZ20013981A3 (en)
EA (1) EA200101157A1 (en)
EE (1) EE200100592A (en)
HU (1) HUP0201098A2 (en)
IL (1) IL145373A0 (en)
NO (1) NO20015488L (en)
PL (1) PL352029A1 (en)
SK (1) SK16212001A3 (en)
WO (1) WO2000068245A1 (en)
ZA (1) ZA200110073B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9376462B2 (en) * 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
CN112334476B (en) * 2019-09-09 2022-03-15 邦泰生物工程(深圳)有限公司 A kind of method of synthesizing chenodeoxycholic acid and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
WO1996027658A1 (en) * 1995-03-06 1996-09-12 Novo Nordisk A/S Stimulation of meiosis
CA2331962A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds

Also Published As

Publication number Publication date
KR20020013541A (en) 2002-02-20
EA200101157A1 (en) 2002-06-27
CZ20013981A3 (en) 2002-02-13
SK16212001A3 (en) 2002-02-05
NO20015488D0 (en) 2001-11-09
ZA200110073B (en) 2003-03-06
BR0010449A (en) 2002-02-13
HUP0201098A2 (en) 2002-08-28
BG106093A (en) 2002-05-31
IL145373A0 (en) 2002-06-30
EE200100592A (en) 2003-02-17
CA2373442A1 (en) 2000-11-16
JP2002544136A (en) 2002-12-24
PL352029A1 (en) 2003-07-28
CN1350543A (en) 2002-05-22
EP1177205A1 (en) 2002-02-06
WO2000068245A1 (en) 2000-11-16
AU4756100A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
HUP0302131A2 (en) Pharmaceutical tramadol salts, pharmaceutical compositions containing them
HUP0104718A2 (en) Micronized eplerenone compositions and process for their preparation
NO20011471L (en) New oral sustained release formulations
AU6461600A (en) Substituted piperidine compounds useful as modulators of chemokine receptor activity
CA2385890A1 (en) Controlled release compositions comprising nimesulide
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
GEP20043161B (en) Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators
DK0750618T3 (en) Oxazolidinone derivatives and pharmaceutical preparations containing them
NO20026064D0 (en) New connections
NO20015226L (en) Tri-aryl acid derivatives such as PPAR receptor ligands, pharmaceutical composition comprising the same and use of the same for the preparation of drug.
NO20023932D0 (en) New connections
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
DE602004011966D1 (en) Heterocyclylverbindungen
NO20020282D0 (en) New diphenylpiperidine derivative
NO304113B1 (en) Crystalline thiagabine hydrochloride monohydrate, pharmaceutical composition comprising it, and use thereof for the manufacture of a medicament
DK1140031T3 (en) Pharmaceutical composition for controlled release with tilidine mesylate as active substance
DE60201259D1 (en) CHEMICAL COMPOUNDS
DE60202590D1 (en) 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
NO20014961L (en) Integrin receptor ligands
NO20015488L (en) 14 &lt;beta&gt; -H-sterols, pharmaceutical compositions comprising them, and the use of these derivatives for the preparation of bio-regulating drugs
DE69813263D1 (en) HYDRAZONO-BENZAZULEN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE PRODUCTS
GEP20043377B (en) Pharmaceutical Complex
NO20052491L (en) New Vitronectin Receptor Antagonist Derivatives, Methods for their Preparation, Their Use as Drugs and Pharmaceutical Compositions Containing the Same
NO20001846L (en) New pharmaceutically active compounds, their preparation and use as ECE inhibitors
NO20013901L (en) Unsaturated cholesterol derivatives and their use in the preparation of meiosis-regulating drugs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application